JR11 - Oral communication - Johannes DORST

JR11 - Oral communication - Johannes DORST

by Johannes DORST

Life & Natural Systems Language & Linguistics CBLanguage: reference and generalCBPSpeaking in public: advice and guides
🎙 Johannes DORST 👥 1K 📅 January 28, 2026 ⏱ 21 min 👁 4 📄 original study 🧭 2026-08-16
Available in: English (current) Français

Keywords

ALSmetabolic alterationspresymptomatictriglyceridesketone bodies

Summary

Johannes Dorst presents metabolic alterations in ALS, highlighting their role as prognostic factors and therapeutic targets. He reviews evidence that high BMI and triglycerides are positive prognostic factors, while high cholesterol is negative. He shows that presymptomatic gene carriers already exhibit reduced body cell mass and phase angle, with gene-specific differences (C9orf72 more affected than SOD1). Surprisingly, presymptomatic carriers show hypometabolism, which may be compensatory. He discusses hypermetabolism in symptomatic ALS and its causes, including hypothalamic and mitochondrial dysfunction. He presents results from the LIPCAL-1 RCT, which showed survival benefit in fast-progressing patients and slowed functional decline, though the primary endpoint was not met. He introduces the ongoing LIPCAL-2 study with increased power. He then presents first results from a ketone bodies RCT, showing reduced neurofilament light chain and stabilized BMI, with larger effects in early and fast-progressing patients. He concludes that metabolic interventions are promising, and discusses limitations and future directions, including the need for better fat composition and potential ketogenic diet approaches.

164 words

Critical Evaluation

Value of the Information & Strength of the Argument

The talk provides valuable insights into metabolic alterations in ALS, combining data from observational cohorts and interventional trials. The argumentation is solid, with clear reasoning linking metabolic changes to disease progression and therapeutic potential. The speaker acknowledges limitations and discusses alternative explanations, enhancing credibility.

Scientific Rigor, Source Quality, Title Accuracy

The presentation is scientifically rigorous, with data from well-defined cohorts and randomized controlled trials. The speaker references his own studies and acknowledges unpublished results. The title accurately reflects the content, and the talk adheres to scientific standards. No public comments were provided for analysis.

103 words

Title / Content Match

The title accurately reflects the content, focusing on metabolic alterations in presymptomatic ALS gene carriers, with additional mention of RCT results.

Quality & Reliability

8/10

The presentation reports findings from well-defined cohorts and randomized controlled trials, with clear methodology and peer-reviewed context. However, some results are preliminary and not yet published, and the speaker acknowledges limitations.

Key Moments

Markers derived by PSI from the transcript: the creator did not define chapters.

Cited Sources

  • LIPCAL-1 study — Randomized controlled trial of high-caloric fat-rich supplement in ALS patients, published in 2020.
  • LIPCAL-2 study — Ongoing follow-up study with increased statistical power, funded by DFG.
  • Ketone bodies RCT — Monocenter randomized controlled trial of oral ketone bodies in ALS patients, recently concluded.

Concurring Sources

  • Ludolph et al., 2020 — LIPCAL-1 study publication showing survival benefit in fast-progressing ALS patients.
  • Dupuis et al., 2004 — Early work on hypermetabolism in ALS.

Dissenting Sources

  • Some studies on cholesterol — Conflicting results on cholesterol as prognostic factor; some studies show no effect or opposite direction.

Contribution & Novelties

This talk provides novel findings on metabolic alterations in presymptomatic ALS gene carriers, including gene-specific differences and hypometabolism. It also presents preliminary results from a ketone bodies RCT, showing potential benefits on neurofilament levels and BMI. The discussion highlights the importance of metabolic interventions as symptomatic therapy.

Pour aller plus loin :

88 words

Radar Profile

The radar profile shows high scores across all dimensions, indicating a well-balanced presentation with strong information content, technical depth, and reliability. The talk is particularly strong in quality and reliability, reflecting its basis in clinical trials and cohort data.

Reliability 8/10